Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disease, with no standard biomarker(s) to detect or confirm its risk at an early stage. The prevalence of AD increases exponentially worldwide in people of ages over 65 and older. Current improvements have unveiled the disease's pathophys...

Descripció completa

Dades bibliogràfiques

Autors principals:	Tapas K. Sur, Tanmoy Mondal, Zarish Noreen, Jheannelle Johnson, Gail Nunlee-Bland, Christopher A. Loffredo, Brent E. Korba, Vijay Chandra, Siddhartha S. Jana, Bernard Kwabi-Addo, Sumit Sarkar, Somiranjan Ghosh
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-06-01
Col·lecció:	Biomarkers in Neuropsychiatry
Matèries:	Alzheimer’s Disease β-amyloid tau APOE Transcriptome analysis Blood Biomarkers
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666144625000024
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!